Quintás-Cardama A - Search Results

1

Treatment of non-small-cell lung cancer with erlotinib or gefitinib.

Cataldo VD, Gibbons DL, Pérez-Soler R, Quintás-Cardama A. Cataldo VD, et al. N Engl J Med. 2011 Mar 10;364(10):947-55. doi: 10.1056/NEJMct0807960. N Engl J Med. 2011. PMID: 21388312 Review.

2

Five-gene signature in non-small-cell lung cancer.

Quintás-Cardama A, Gibbons DL. Quintás-Cardama A, et al. N Engl J Med. 2007 Apr 12;356(15):1582-3; author reply 1583. N Engl J Med. 2007. PMID: 17436429 No abstract available.

3

Azacitidine for the treatment of myelodysplastic syndrome.

Cataldo VD, Cortes J, Quintás-Cardama A. Cataldo VD, et al. Expert Rev Anticancer Ther. 2009 Jul;9(7):875-84. doi: 10.1586/era.09.61. Expert Rev Anticancer Ther. 2009. PMID: 19589026 Review.

4

Nilotinib.

Quintás-Cardama A, Kim TD, Cataldo V, le Coutre P. Quintás-Cardama A, et al. Recent Results Cancer Res. 2010;184:103-17. doi: 10.1007/978-3-642-01222-8_8. Recent Results Cancer Res. 2010. PMID: 20072834 Review.

5

The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm.

Gibbons DL, Pricl S, Kantarjian H, Cortes J, Quintás-Cardama A. Gibbons DL, et al. Cancer. 2012 Jan 15;118(2):293-9. doi: 10.1002/cncr.26225. Epub 2011 Jul 5. Cancer. 2012. PMID: 21732333 Free PMC article.

6

Molecular dynamics reveal BCR-ABL1 polymutants as a unique mechanism of resistance to PAN-BCR-ABL1 kinase inhibitor therapy.

Gibbons DL, Pricl S, Posocco P, Laurini E, Fermeglia M, Sun H, Talpaz M, Donato N, Quintás-Cardama A. Gibbons DL, et al. Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3550-5. doi: 10.1073/pnas.1321173111. Epub 2014 Feb 18. Proc Natl Acad Sci U S A. 2014. PMID: 24550512 Free PMC article.

7

Through the open door: Preferential binding of dasatinib to the active form of BCR-ABL unveiled by in silico experiments.

Laurini E, Posocco P, Fermeglia M, Gibbons DL, Quintás-Cardama A, Pricl S. Laurini E, et al. Mol Oncol. 2013 Oct;7(5):968-75. doi: 10.1016/j.molonc.2013.06.001. Epub 2013 Jun 15. Mol Oncol. 2013. PMID: 23816609 Free PMC article.

8

Sequencing of subcloned PCR products facilitates earlier detection of BCR-ABL1(T315I) and other mutants compared to direct sequencing of the ABL1 kinase domain.

Quintás-Cardama A, Gibbons DL, Kantarjian H, Talpaz M, Donato N, Cortes J. Quintás-Cardama A, et al. Leukemia. 2008 Apr;22(4):885-8. doi: 10.1038/leu.2008.42. Epub 2008 Feb 28. Leukemia. 2008. PMID: 18305550 No abstract available.

9

Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia.

Quintás-Cardama A, Gibbons DL, Cortes J, Bobadilla D, Slovak ML, Kantarjian H, Abruzzo LV. Quintás-Cardama A, et al. Leukemia. 2008 Apr;22(4):877-8. doi: 10.1038/sj.leu.2404981. Epub 2007 Oct 11. Leukemia. 2008. PMID: 17928880 No abstract available.

10

CAR T-Cell Therapy in Large B-Cell Lymphoma.

Quintás-Cardama A. Quintás-Cardama A. N Engl J Med. 2018 Mar 15;378(11):1065. doi: 10.1056/NEJMc1800913. N Engl J Med. 2018. PMID: 29542306 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters